Tech Company M&A Transactions
AxioMx Acquisition
On 11/11/2015, AxioMx was purchased by Abcam. The transaction price was $45 million.
Transaction Overview
Company Name
Acquired By
Announced On
11/11/2015
Transaction Type
M&A
Amount
$45,000,000
M&A Terms
The life science research tools supplier said Wednesday it has signed an agreement to buy AxioMx on a cash-free/debt-free basis for $20 million upfront with further performance-based payments totaling $25 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
688 E Main St.
Branford, CT 06405
USA
Branford, CT 06405
USA
Phone
Website
Email Address
Overview
AxioMx has developed synthetic recombinant antibody libraries with greater than ten billion unique clones. Diversity in our libraries is restricted to the most variable positions in the complementarity determining regions (CDRs) of natural antibody sequences.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher McLeod
Chief Scientific Officer
Michael Weiner
VP - Sales
Tom Thompson
Browse more venture capital transactions:
Prev: 11/11/2015: Swrve venture capital transaction
Next: 11/11/2015: DeliverCareRx venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs